Skip to main content
Immunology logoLink to Immunology
. 1992 Feb;75(2):224–231.

IgVH determined genetic restriction of a non-internal image monoclonal anti-idiotypic vaccine against Semliki Forest virus.

T A Oosterlaken 1, M Harmsen 1, G L Ekstijn 1, C A Kraaijeveld 1, H Snippe 1
PMCID: PMC1384698  PMID: 1551685

Abstract

Two monoclonal anti-idiotypic antibodies (ab2 mAb), designated 1.13A112 (IgG2a) and 1.13A321 (IgG1) and induced against Semliki Forest virus (SFV)-neutralizing mAb UM 1.13, were investigated with regard to their vaccine potential. 1.13A321 was coupled with glutaraldehyde to keyhole limpet haemocyanin (KLH) and mixed with the adjuvant Quil A. Then when injected subcutaneously into BALB/c mice, it evoked high levels of SFV-neutralizing anti-anti-idiotypic antibodies in serum. In contrast, 1.13A112 had to be indirectly cross-linked to KLH with anti-mouse immunoglobulin to induce a low neutralizing antibody response. Competition binding assay revealed that 1.13A112 and 1.13A321 were completely competitive. Furthermore, SFV neutralization by UM 1.13 and anti-anti-idiotypic (ab3) serum was blocked equally well by either ab2 mAb. These results indicate that ab1 (UM 1.13) and ab3 share at least one antigen-combining site-related idiotope. Induction of SFV-neutralizing antibodies is genetically restricted. Rabbit anti-anti-idiotypic sera against 1.13A321 and 1.13A112 contained no SFV-neutralizing activity. Moreover, in DBA/2, C57BL/6J, CAL-20, and CB-20 mice 1.13A321 did not develop SFV-neutralizing ab3 antibodies in contrast to BALB.K, 129, SWISS, and BAB-14 mice. CAL-20, CB-20, and BAB-14 mice are congenic strains with an inbred background of BALB/c. CB-20 mice derived both IgCH and IgVH from donor strain C57BL/Ka, while BAB-14 mice derived IgCH from C57BL/Ka mice but retained IgVH from BALB/c mice. Clearly, induction of SFV-neutralizing antibodies by 1.13A321 in BAB-14 mice is dependent on IgVH of BALB/c origin. The results suggest that 1.13A321 binds to a paratope-associated recurring idiotope and almost certainly does not bear the internal image of the discontinuous neutralization epitope recognized by mAb UM 1.13. The latter suggestion is sustained by the observation that 1.13A112 and 1.13A321 do not bind to cell receptors.

Full text

PDF
224

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akerström B., Brodin T., Reis K., Björck L. Protein G: a powerful tool for binding and detection of monoclonal and polyclonal antibodies. J Immunol. 1985 Oct;135(4):2589–2592. [PubMed] [Google Scholar]
  2. Boere W. A., Harmsen T., Vinjé J., Benaissa-Trouw B. J., Kraaijeveld C. A., Snippe H. Identification of distinct antigenic determinants on Semliki Forest virus by using monoclonal antibodies with different antiviral activities. J Virol. 1984 Nov;52(2):575–582. doi: 10.1128/jvi.52.2.575-582.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bradish C. J., Allner K., Maber H. B. The virulence of original and derived strains of Semliki forest virus for mice, guinea-pigs and rabbits. J Gen Virol. 1971 Aug;12(2):141–160. doi: 10.1099/0022-1317-12-2-141. [DOI] [PubMed] [Google Scholar]
  4. Garoff H., Frischauf A. M., Simons K., Lehrach H., Delius H. Nucleotide sequence of cdna coding for Semliki Forest virus membrane glycoproteins. Nature. 1980 Nov 20;288(5788):236–241. doi: 10.1038/288236a0. [DOI] [PubMed] [Google Scholar]
  5. Hiernaux J. R. Idiotypic vaccines and infectious diseases. Infect Immun. 1988 Jun;56(6):1407–1413. doi: 10.1128/iai.56.6.1407-1413.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kraaijeveld C. A., Jansen J., Benaissa-Trouw B., Snippe H. Delayed-type hypersensitivity in mice after infection with avirulent Semliki Forest virus. Brief report. Arch Virol. 1983;78(1-2):115–118. doi: 10.1007/BF01310865. [DOI] [PubMed] [Google Scholar]
  7. Lieberman R., Potter M., Humphrey W., Jr, Chien C. C. Idiotype of inulin-binding antibodies and myeloma proteins controlled by genes linked to the allotype locus of the mouse. J Immunol. 1976 Dec;117(6):2105–2111. [PubMed] [Google Scholar]
  8. Misplon J. A., Reeves J. P., Harvath L., Rubinstein L. J., Epstein S. L. Induction of antigen-specific immunity with monoclonal anti-idiotypic antibodies in vivo: differences in potency and comparison of immunochemical properties. Eur J Immunol. 1989 Dec;19(12):2361–2365. doi: 10.1002/eji.1830191227. [DOI] [PubMed] [Google Scholar]
  9. Morein B., Sundquist B., Höglund S., Dalsgaard K., Osterhaus A. Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses. 1984 Mar 29-Apr 4Nature. 308(5958):457–460. doi: 10.1038/308457a0. [DOI] [PubMed] [Google Scholar]
  10. Nakane P. K., Kawaoi A. Peroxidase-labeled antibody. A new method of conjugation. J Histochem Cytochem. 1974 Dec;22(12):1084–1091. doi: 10.1177/22.12.1084. [DOI] [PubMed] [Google Scholar]
  11. Oosterlaken T. A., Harmsen M., Jhagjhoor-Singh S. S., Ekstijn G. L., Kraaijeveld C. A., Snippe H. A protective monoclonal anti-idiotypic vaccine to lethal Semliki Forest virus infection in BALB/c mice. J Virol. 1991 Jan;65(1):98–102. doi: 10.1128/jvi.65.1.98-102.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Oosterlaken T. A., Harmsen M., Kraaijeveld C. A., Snippe H. Blocking by anti-idiotypic antibodies of monoclonal antibody-mediated protection against lethal Semliki Forest virus in mice. Scand J Immunol. 1990 Feb;31(2):159–165. doi: 10.1111/j.1365-3083.1990.tb02755.x. [DOI] [PubMed] [Google Scholar]
  13. Oosterlaken T. A., Harmsen M., Tangerman C., Schielen P., Kraaijeveld C. A., Snippe H. A neutralization-inhibition enzyme immunoassay for anti-idiotypic antibodies that block monoclonal antibodies neutralizing Semliki Forest virus. J Immunol Methods. 1988 Dec 9;115(2):255–261. doi: 10.1016/0022-1759(88)90295-5. [DOI] [PubMed] [Google Scholar]
  14. Riblet R., Blomberg B., Weigert M., Lieberman R., Taylor B. A., Potter M. Genetics of mouse antibodies. I. Linkage of the dextran response locus, VH-DEX, to allotype. Eur J Immunol. 1975 Nov;5(11):775–777. doi: 10.1002/eji.1830051109. [DOI] [PubMed] [Google Scholar]
  15. Sacks D. L., Sher A. Evidence that anti-idiotype induced immunity to experimental African trypanosomiasis is genetically restricted and requires recognition of combining site-related idiotopes. J Immunol. 1983 Sep;131(3):1511–1515. [PubMed] [Google Scholar]
  16. Schick M. R., Dreesman G. R., Kennedy R. C. Induction of an anti-hepatitis B surface antigen response in mice by noninternal image (Ab2 alpha) anti-idiotypic antibodies. J Immunol. 1987 May 15;138(10):3419–3425. [PubMed] [Google Scholar]
  17. Snijders A., Benaissa-Trouw B. J., Oosterlaken T. A., Puijk W. C., Posthumus W. P., Meloen R. H., Boere W. A., Oosting J. D., Kraaijeveld C. A., Snippe H. Identification of linear epitopes on Semliki Forest virus E2 membrane protein and their effectiveness as a synthetic peptide vaccine. J Gen Virol. 1991 Mar;72(Pt 3):557–565. doi: 10.1099/0022-1317-72-3-557. [DOI] [PubMed] [Google Scholar]
  18. Uytdehaag F. G., Osterhaus A. D. Induction of neutralizing antibody in mice against poliovirus type II with monoclonal anti-idiotypic antibody. J Immunol. 1985 Feb;134(2):1225–1229. [PubMed] [Google Scholar]
  19. Vlaspolder F., Kraaijeveld C. A., van Buuren R., Harmsen M., Benaissa-Trouw B. J., Snippe H. Prophylaxis and therapy of virulent encephalomyocarditis virus infection in mice by monoclonal antibodies. Brief report. Arch Virol. 1988;98(1-2):123–130. doi: 10.1007/BF01321013. [DOI] [PubMed] [Google Scholar]
  20. Zhou E. M., Lohman K. L., Kennedy R. C. Administration of noninternal image monoclonal anti-idiotypic antibodies induces idiotype-restricted responses specific for human immunodeficiency virus envelope glycoprotein epitopes. Virology. 1990 Jan;174(1):9–17. doi: 10.1016/0042-6822(90)90048-v. [DOI] [PubMed] [Google Scholar]
  21. van Tiel F. H., Harmsen T., Wagenaar M., Boere W. A., Kraaijeveld C. A., Snippe H. Rapid determination of neutralizing antibodies to Semliki Forest virus in serum by enzyme immunoassay in cell culture with virus-specific monoclonal antibodies. J Clin Microbiol. 1986 Oct;24(4):665–668. doi: 10.1128/jcm.24.4.665-668.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES